Ezetimibe & Rosuvastatin Tablets 10mg/10mg, 10mg/20mg, 10mg/40mg Tablet

What is Ezetimibe & Rosuvastatin Tablets 10mg/10mg, 10mg/20mg, 10mg/40mg Tablet?

Ezetimibe and Rosuvastatin Tablets combine ezetimibe with rosuvastatin to provide complementary lipid-lowering activity. The formulation is available in 10 mg/10 mg, 10 mg/20 mg and 10 mg/40 mg strengths and is used as part of the management of elevated cholesterol and other lipid disorders when combination therapy is clinically appropriate.

Uses / Indications

Ezetimibe and rosuvastatin tablets may be used in the management of lipid disorders, including:

• Primary hypercholesterolaemia
• Elevated low-density lipoprotein cholesterol (LDL-C)
• Mixed dyslipidaemia in appropriate clinical settings
• Patients requiring additional LDL-C reduction despite statin therapy or where combination therapy is indicated
• Selected patients requiring intensive lipid-lowering treatment according to clinical assessment

Treatment should be used together with appropriate dietary and lifestyle measures where indicated.

Benefits

• Combines two complementary lipid-lowering mechanisms in one tablet.
• Ezetimibe reduces intestinal absorption of cholesterol.
• Rosuvastatin reduces hepatic cholesterol synthesis.
• Helps reduce LDL cholesterol as part of an appropriate lipid-management plan.
• Available in multiple strengths to support different treatment requirements.

Side Effects

Common Side Effects

Possible side effects may include:

• Headache
• Nausea
• Abdominal discomfort
• Diarrhoea
• Constipation
• Muscle pain
• Fatigue
• Increased liver enzymes

Less Common or Serious Side Effects

Less common but clinically important reactions may include:

• Significant muscle pain or weakness
• Myopathy or rhabdomyolysis
• Liver-related abnormalities
• Hypersensitivity or allergic reactions
• Severe skin reactions
• Pancreatitis in rare circumstances

Patients experiencing unexplained severe muscle pain, weakness, dark urine, or other significant symptoms should seek medical attention.

How Does It Work?

Ezetimibe

Ezetimibe reduces the absorption of cholesterol at the intestinal brush border by inhibiting the NPC1L1 cholesterol transport pathway. This decreases the amount of cholesterol delivered to the liver and contributes to lowering circulating LDL cholesterol.

Rosuvastatin

Rosuvastatin is an HMG-CoA reductase inhibitor, commonly known as a statin. It reduces hepatic cholesterol synthesis and increases the expression of LDL receptors in the liver, promoting removal of LDL cholesterol from the bloodstream.

Combination Action

The two ingredients act through complementary pathways: ezetimibe reduces intestinal cholesterol absorption, while rosuvastatin reduces cholesterol synthesis and increases hepatic LDL clearance. Their combination can therefore provide additional LDL-C lowering compared with either mechanism alone.

Dosage Guidelines

The appropriate strength and treatment duration depend on the patient’s lipid profile, cardiovascular risk, previous treatment, treatment response, tolerability, and other clinical factors.

The exact dose and treatment duration should follow the approved product information and the recommendation of a qualified healthcare professional.

For tablets:

• Take exactly as prescribed.
• Swallow the tablet with sufficient water.
• The tablet should not be crushed, split or chewed unless permitted by the approved product information.
• Follow the prescribed treatment schedule.
• Continue recommended dietary and lifestyle measures.
• Do not alter the dose without professional advice.

When Not to Use

Ezetimibe and rosuvastatin should generally not be used in patients with:

• Known hypersensitivity to ezetimibe, rosuvastatin, or any component of the formulation
• Active liver disease or unexplained persistent elevations in serum transaminases, where contraindicated by the approved product information
• Pregnancy
• Breastfeeding

Patients with a history of liver disease, renal impairment, thyroid disorders, or previous muscle-related adverse effects from lipid-lowering medicines should receive appropriate professional assessment before treatment.

Drug / Product Interactions

Clinically relevant interactions may occur with medicines that affect rosuvastatin exposure or increase the risk of muscle-related adverse effects.

Important interaction considerations may include:

• Cyclosporine
• Gemfibrozil and certain other fibrates
• Warfarin and other vitamin K antagonists
• Certain antiviral medicines
• Antacids containing aluminium or magnesium
• Other medicines that may increase statin-associated muscle toxicity

Patients taking multiple medicines should provide their complete medication list to their healthcare professional before starting treatment.

Safety Advice

Overdose

If an overdose is suspected, seek immediate medical attention or contact an appropriate poison-control or emergency medical service.

Missed Dose

Take the missed dose when remembered unless it is nearly time for the next scheduled dose. If the next dose is due soon, skip the missed dose and continue with the regular schedule. Do not double the next dose unless specifically instructed by a healthcare professional.

Pregnancy

Ezetimibe and rosuvastatin should not generally be used during pregnancy. Rosuvastatin is contraindicated during pregnancy because cholesterol and other products of cholesterol biosynthesis are important for fetal development.

Breastfeeding

Treatment with rosuvastatin is generally not recommended during breastfeeding. The use of this combination during breastfeeding should follow the approved product information and professional medical advice.

Children

Use in children and adolescents should follow the approved product information and age-specific clinical recommendations.

Elderly Patients

Older patients may require appropriate assessment of renal function, concurrent medicines, and risk factors for muscle-related adverse effects.

Renal Impairment

Renal function should be considered when selecting an appropriate rosuvastatin-containing regimen. Some patients with renal impairment may require a different strength or additional monitoring.

Hepatic Impairment

Patients with active liver disease or unexplained persistent elevations in liver enzymes should be assessed before treatment. Appropriate liver-function monitoring may be required according to clinical circumstances.

General Instructions

• Take the medicine according to the prescribed schedule.
• Swallow the tablet with sufficient water.
• Follow the recommended diet and lifestyle measures provided by the healthcare professional.
• Do not change the strength or dose without professional advice.
• Inform the healthcare professional about other medicines being taken.
• Report unexplained muscle pain, tenderness, or weakness.
• Keep the medicine in its original packaging where appropriate.
• Do not share prescription medicines with other people.

Special Dietary / Lifestyle Tips

A heart-healthy dietary pattern and appropriate physical activity may form part of the overall management of elevated cholesterol.

Limit excessive intake of saturated fats and follow dietary recommendations provided by a healthcare professional. Lifestyle measures should complement, rather than replace, prescribed lipid-lowering treatment where treatment is indicated.

Comparison with Other Treatments

Ezetimibe and rosuvastatin combine intestinal cholesterol absorption inhibition with statin-mediated reduction of hepatic cholesterol synthesis. Ezetimibe alone acts primarily on intestinal cholesterol absorption, while rosuvastatin alone primarily reduces hepatic cholesterol synthesis.

Other lipid-lowering therapies, including other statins, fibrates, bile acid sequestrants, PCSK9-targeting therapies, and other agents, have different mechanisms and clinical roles. Treatment selection depends on LDL-C levels, cardiovascular risk, tolerability, concurrent medicines, and the approved indication.

Precautions & Warnings

• Confirm any history of allergy or hypersensitivity to ezetimibe, rosuvastatin, or related medicines.
• Do not use during pregnancy.
• Breastfeeding considerations should follow the approved product information.
• Inform the healthcare professional about previous statin-associated muscle problems.
• Report unexplained muscle pain, tenderness, or weakness promptly.
• Seek medical attention for severe muscle symptoms, particularly when accompanied by dark urine or marked weakness.
• Patients with liver disease require appropriate clinical assessment.
• Renal function should be considered when selecting the appropriate rosuvastatin strength.
• Inform the healthcare professional about all prescription, non-prescription, and herbal medicines being used.
• Periodic lipid and other laboratory assessments may be recommended according to clinical circumstances.

Can I Use It With Other Medicines?

Generally Compatible With

Ezetimibe and rosuvastatin may be used with many medicines when clinically appropriate. The complete medication profile should be reviewed before treatment because interaction risk varies between medicines.

Use With Caution / Avoid

Professional advice is particularly important when the product is used with:

• Cyclosporine
• Gemfibrozil or other fibrates
• Certain antiviral medicines
• Warfarin or other vitamin K antagonists
• Aluminium- or magnesium-containing antacids
• Other medicines associated with increased risk of muscle toxicity

Do not start, stop, or change other medicines without appropriate medical advice.

Storage

Store according to the storage conditions stated on the approved product label and package insert.

• Keep properly closed.
• Protect from excessive heat.
• Protect from moisture.
• Keep out of reach of children.
• Do not use after the expiry date.
• Keep in the original packaging where appropriate.

Frequently Asked Questions

1. What are Ezetimibe and Rosuvastatin Tablets used for?

Ezetimibe and rosuvastatin tablets are used as part of the management of elevated cholesterol and other appropriate lipid disorders, particularly when additional LDL-C reduction is required.

2. What are the available strengths of this formulation?

The formulation is available as 10 mg/10 mg, 10 mg/20 mg, and 10 mg/40 mg of ezetimibe and rosuvastatin, respectively.

3. How do Ezetimibe and Rosuvastatin work together?

Ezetimibe reduces intestinal cholesterol absorption, while rosuvastatin reduces hepatic cholesterol synthesis and increases LDL clearance from the bloodstream. The two mechanisms provide complementary lipid-lowering activity.

4. How should Ezetimibe and Rosuvastatin tablets be taken?

The tablet should be taken exactly as prescribed and swallowed with sufficient water. The selected strength and treatment duration should be determined according to the approved product information and clinical assessment.

5. Can this combination be used during pregnancy?

Ezetimibe and rosuvastatin should not generally be used during pregnancy. Appropriate medical advice should be obtained if pregnancy occurs during treatment.

6. What should I do if I experience muscle pain?

Unexplained or persistent muscle pain, tenderness, or weakness should be reported to a healthcare professional. Severe muscle symptoms, particularly with dark urine or marked weakness, require prompt medical attention.

7. Can Ezetimibe and Rosuvastatin be taken with other medicines?

The combination can interact with certain medicines, including cyclosporine, fibrates, some antiviral medicines, warfarin, and certain antacids. A healthcare professional should review the patient’s complete medication profile.

8. How should Ezetimibe and Rosuvastatin tablets be stored?

Store the product according to the conditions stated on the approved product label and package insert, and keep it out of reach of children.